Biora Therapeutics, Inc. Common Stock
BIOR
BIOR was delisted on the 10th of December, 2024.
48 hedge funds and large institutions have $199M invested in Biora Therapeutics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 10 closing their positions.
139% more capital invested
Capital invested by funds: $83.1M → $199M (+$116M)
90% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 10
67% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 9
23% more funds holding
Funds holding: 39 → 48 (+9)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.77M |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$2.43M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.31M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$1.5M |
| 5 |
BC
Birchview Capital
Burlington,
Vermont
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$3.61M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$1.74M |
| 3 |
RI
RTW Investments
New York
|
-$1.03M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$835K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$682K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Alyeska Investment Group
Chicago,
Illinois
| – | -$682K | -302 | Closed |
|
|
SCM
52
Stonepine Capital Management
Bend,
Oregon
| – | -$614K | -272 | Closed |
|
53
Ameriprise
Minneapolis,
Minnesota
| – | -$603K | -267 | Closed |
|
|
MS
54
Maven Securities
St Helier,
Jersey
| – | -$577K | -258 | Closed |
|
|
CCM
55
CAAS Capital Management
New York
| – | -$361K | -160 | Closed |
|
56
Squarepoint
New York
| – | -$133K | -59 | Closed |
|
|
HF
57
HRT Financial
New York
| – | -$126K | -56 | Closed |
|
58
HSBC Holdings
London,
United Kingdom
| – | -$91K | -41 | Closed |
|
BIOR Hedge Fund Activity: Q4 2020 in Review
48 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Biora Therapeutics, Inc. Common Stock (BIOR) for Q4 2020, worth a combined $199M — up 139% from $83.1M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new BIOR positions and 10 closed out — a net gain of 9 holders — while 15 added to existing stakes and 9 trimmed.
The largest buyer was BlackRock, adding an estimated $2.77M. The largest seller was Armistice Capital, exiting entirely with an estimated $3.61M sold.
- 48 institutional investors held Biora Therapeutics, Inc. Common Stock (BIOR) as of Q4 2020, up from 39 in Q3 2020.
- Funds reported $199M of Biora Therapeutics, Inc. Common Stock stock for Q4 2020, up 139% quarter-over-quarter.
- 19 funds opened new Biora Therapeutics, Inc. Common Stock positions in Q4 2020 and 10 closed out, a net change of +9 holders.
- The largest Biora Therapeutics, Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $2.77M added.
- The largest Biora Therapeutics, Inc. Common Stock seller in Q4 2020 was Armistice Capital, an estimated $3.61M sold.
Based on aggregated 13F filings for Q4 2020.